Skip to content

● Live

Top 100 Artists

Artists Artworks Markets Indices Portfolio Solutions Developers

Get App </>Docs

LiveArt · Art as an asset class

The art market, tracked daily — not just on sale events.

LiveArt Estimate™ revalues every work, every day. LiveArt Index family — institutional benchmarks for art as an asset class. 50+ rules-based indices — plus individual price indices for 40,000+ artists — updated daily in five currencies. Built on 30M+ auction records since 1986.

Weekly market brief

Mondays. The numbers, the top results, what moved. No PR.

Used by 320+ galleries, 14 auction houses, 80+ family offices.

The financial intelligence layer for fine art and cultural assets.

Download the App

Explore

Artists
Artist Screener
Search by Image
Market Pulse
Auction sales
Indices
Portfolio
Get the App

Products

LiveArt Estimate™
Artist Analytics
Art Market Indices
AI Advisor
Cataloguing
Deal Intelligence
Browser Extension
Mobile App

Data & API

Methodology
Developers
API reference
Enterprise
Image rights
Become a Data Partner

Solutions

Galleries
Auction houses
Advisors & wealth
Insurers
Family offices
Researchers · Press

Company

About
Careers
Methodology paper
Contact

© Live Art AI, Inc. · The data layer for the art market.

Terms Privacy Image Rights Cookies Security Accessibility

LiveArt Estimate™ is a model output, not investment advice. Past performance does not guarantee future results.

Home Artists Markets Portfolio

Artwork record

Mescaline (preview)

Mescaline

Year: 2014
Medium: lenticular-digital printing on PETG plastic
Size: 56.5 × 56.5 cm
Category: Prints & multiples

The full valuation is for members

LiveArt Estimate™, price history, past sales, comparables and the outlook — free with an account.

Similar works

Vipera Lebetina
Lanatoside B
Psilocybin
Meprobamate; and Controlled Substances Key Spot
Meprobamate
CONTROLLED SUBSTANCES KEY SPOT; AND MEPROBAMATE

Clear images and prices are available to members.